Literature DB >> 25231185

Reporting guidelines for pharmacoepidemiological studies are urgently needed.

Mahyar Etminan1.   

Abstract

Mesh：

Year:  2014        PMID： 25231185     DOI： 10.1136/bmj.g5511

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  The Reporting Of MEdication use in Observational studies (ROMEO) Statement.

Authors:  Susan G Poole; J Simon Bell; Michael J Dooley; Carl M Kirkpatrick
Journal:  Eur J Clin Pharmacol       Date:  2015-05-09       Impact factor: 2.953

2. 

Authors:  Sinéad M Langan; Sigrún A J Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sørensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  CMAJ       Date:  2019-06-24       Impact factor: 8.262

3.  The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).

Authors:  Sinéad M Langan; Sigrún Aj Schmidt; Kevin Wing; Vera Ehrenstein; Stuart G Nicholls; Kristian B Filion; Olaf Klungel; Irene Petersen; Henrik T Sorensen; William G Dixon; Astrid Guttmann; Katie Harron; Lars G Hemkens; David Moher; Sebastian Schneeweiss; Liam Smeeth; Miriam Sturkenboom; Erik von Elm; Shirley V Wang; Eric I Benchimol
Journal:  BMJ       Date:  2018-11-14

4.  Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes.

Authors:  Lauren R Rodgers; Michael N Weedon; William E Henley; Andrew T Hattersley; Beverley M Shields
Journal:  BMJ Open       Date:  2017-10-12       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.